Autor: Grela-Wojewoda, Aleksandra - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: BRAF/MEK inhibitors in the systemic treatment of advanced skin melanoma
Autorzy:: Kruczała, Maksymilian
Grela-Wojewoda, Aleksandra
Ziobro, Marek
Powiązania:: https://bibliotekanauki.pl/articles/1062946.pdf
Data publikacji:: 2017
Wydawca:: Medical Education
Tematy:: BRAF inhibitors
MEK inhibitors
melanoma
targeted therapy
Opis:: A major progress has been made in the systemic treatment of advanced melanoma over the last few years. Targeted therapy has proven highly active, which is reflected in the response rate as well as progression-free survival and overall survival times. The paper aims to summarize the current knowledge on the available BRAF and MEK inhibitors.
Źródło:: OncoReview; 2017, 7, 3; 139-143
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Skocz do pozycji: 2.

Tytuł:: Everolimus – effectively reverses acquired resistance on endocrine therapy of patients with advanced breast cancer. A case report
Autorzy:: Grela-Wojewoda, Aleksandra
Kruczała, Maksymilian
Cedrych, Ida
Powiązania:: https://bibliotekanauki.pl/articles/1065382.pdf
Data publikacji:: 2014
Wydawca:: Medical Education
Tematy:: breast cancer
endocrine therapy
everolimus
Opis:: Breast cancer is the most common malignancy among women in Poland. Endocrine therapy is the first line of treatment in hormone-receptor-positive advanced breast cancer. Progression during endocrine therapy is unavoidable. Administration of mTOR inhibitor gives a chance of reversing the acquired resistance. This paper presents a case report of a patient with metastatic breast cancer successfully treated with everolimus added to endocrine therapy.
Źródło:: OncoReview; 2014, 4, 3; A117-120
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Skocz do pozycji: 3.

Tytuł:: Advanced skin melanoma – systemic treatment
Autorzy:: Kruczała, Maksymilian
Ziobro, Marek
Grela-Wojewoda, Aleksandra
Cedrych, Ida
Powiązania:: https://bibliotekanauki.pl/articles/1065316.pdf
Data publikacji:: 2015
Wydawca:: Medical Education
Tematy:: immunotherapy
melanoma
systemic therapy
Opis:: In Poland, morbidity and mortality rates for melanoma are constantly increasing. In the case of inoperable disease or distant metastases, prognosis remains poor. For many years, dacarbazine has been the gold standard in systemic treatment. Recently, a significant progress in melanoma therapy has been observed. Introducing targeted therapy or immunotherapy significantly improved treatment outcomes. This review paper presents current knowledge on systemic treatment of advanced melanoma, including treatment availability in Poland.
Źródło:: OncoReview; 2015, 5, 3; A133-138
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Informacja